| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
2 companies
Oyler John is a Chief Executive Officer at BEIGF with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 90 sells.
Estimated insider holdings value: $583K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 6, 2025 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 5,127 | $252.77 | $1,295,946.05 | -39.7% | +24.6% | - | |
| Mar 10, 2025 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sale+OE | 41,210 | $242.67 | $10,000,482.50 | -21.1% | +8.7% | +25.9% | |
| Mar 7, 2025 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sale+OE | 58,590 | $249.13 | $14,596,247.17 | -16.6% | +4.0% | +21.9% | |
| Mar 6, 2025 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sale+OE | 40,109 | $259.15 | $10,394,328.73 | -30.9% | +0.5% | +17.2% | |
| Mar 3, 2025 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sale+OE | 101,000 | $244.30 | $24,674,638.28 | -17.4% | +0.2% | +21.0% | |
| Oct 8, 2024 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 14,829 | $232.89 | $3,453,597.37 | -26.7% | -23.3% | +49.1% | |
| Jun 24, 2024 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 2,789 | $159.58 | $445,069.66 | -87.5% | +26.5% | +67.6% | |
| Jun 17, 2024 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 1,281 | $159.35 | $204,124.55 | -48.5% | +23.3% | +59.4% | |
| Apr 11, 2024 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 50,000 | $149.50 | $7,475,024.09 | -19.1% | -0.1% | +57.6% | |
| Mar 13, 2024 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 50,000 | $167.36 | $8,368,016.67 | -26.0% | -10.1% | +44.3% |